Zuellig Pharma, a leading healthcare services provider in Asia, has launched eZConsult—a virtual care mobile app to address the growing need for teleconsultation amidst lockdowns and restricted movement during the global COVID-19 pandemic.
Co-created with doctors and patients, eZConsult is a seamless solution that allows simple, secure and safe access to healthcare. The app connects users with an extensive panel of healthcare professionals across different specialties. It also partners with key healthcare stakeholders such as retail pharmacies, laboratories and fintech companies that can provide advice, support and services to patients through the platform.
“The need to mitigate exposure and reduce the spread of COVID-19 allows us to re-imagine how healthcare should be delivered and experienced,” said Kidit Afable, Zuellig Pharma Philippines vice president for strategy and innovation.
Afable explained that the need for alternatives to face-to-face doctor consultations is particularly urgent, with people worried about infectious diseases, and healthcare services being overwhelmed by COVID-19. This means many people are putting-off seeing a doctor to the detriment of their health. eZConsult allows patients to seek the care they need wherever they are.
For doctors, eZConsult was designed to be complementary and supplementary to current brick-and-mortar practice. It makes managing patients easy. eZConsult schedules appointments, provides secure options for virtual consultations and is an easy-to-use platform for secure electronic medical records.
For patients, eZConsult provides end-to-end healthcare services, from booking a virtual consult, getting a prescription, uploading diagnostics, e-payment, to support in managing conditions. For example, prescriptions generated through the platform for the patient can be routed to the pharmacy of the patient’s choice, fulfilled and delivered to their home.
“eZConsult is backed by Zuellig Pharma’s century of experience in making healthcare more accessible in Asia,” said Maikel Kuijpers, Zuellig Pharma Philippines chief executive.
“The virtual care network will launch in the Philippines, followed by other markets in the region,” he said.
“We will continue to innovate and improve our platform to push the boundaries of virtual healthcare services. The model we are developing will transform healthcare by connecting health services through one platform and supporting patients wherever they are to take care of their health, ultimately improving health outcomes,” said Kujipers.
